Nicola Wealth Management Ltd. Biogen Inc. Transaction History

Nicola Wealth Management Ltd.

  • $1.05 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$212.02 - $267.71 $3.07 Million - $3.88 Million
14,500 Added 58.0%
39,500 $8.52 Million
Q4 2023

Feb 08, 2024
BUY
$222.59 - $267.94 $667,770 - $803,820
3,000 Added 13.64%
25,000 $6.47 Million
Q3 2023

Nov 14, 2023
BUY
$253.3 - $285.89 $5.57 Million - $6.29 Million
22,000 New
22,000 $5.65 Million

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Nicola Wealth Management Ltd. Portfolio

Follow Nicola Wealth Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicola Wealth Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Nicola Wealth Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email